HBW
GNOM icon

Hazlett, Burt & Watson’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Hazlett, Burt & Watson’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
25
– – ﹤0.01% 878
2026
Q1 		$1K Hold
25
– – ﹤0.01% 886
2025
Q4 		$1K Hold
25
– – ﹤0.01% 894
2025
Q3 		$1K Hold
25
– – ﹤0.01% 847
2025
Q2 		$1K Hold
25
– – ﹤0.01% 765
2025
Q1 		$1K Hold
25
– – ﹤0.01% 761
2024
Q4 		$1K Hold
25
– – ﹤0.01% 730
2024
Q3 		$1K Hold
25
– – ﹤0.01% 701
2024
Q2 		$1K Hold
25
– – ﹤0.01% 678
2024
Q1 		$1K Hold
25
– – ﹤0.01% 675
2023
Q4 		$1K Hold
25
– – ﹤0.01% 651
2023
Q3 		$1K Sell
25
-484
-95% -$22K ﹤0.01% 676
2023
Q2 		$24K Hold
509
– – 0.02% 389
2023
Q1 		$25K Hold
509
– – 0.02% 360
2022
Q4 		$26K Sell
509
-161
-24% -$8.3K 0.02% 354
2022
Q3 		$33K Hold
670
– – 0.03% 307
2022
Q2 		$33K Hold
670
– – 0.03% 314
2022
Q1 		$40K Buy
+670
New +$42.3K 0.03% 312

Other funds holding GNOM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
SWA
Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

Hazlett, Burt & Watson's GNOM Position: Q2 2026 in Review

Hazlett, Burt & Watson held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 25 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Hazlett, Burt & Watson first reported a position in GNOM in Q1 2022 and has held it in 18 quarters since. The position peaked at $40K in Q1 2022. 17 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Hazlett, Burt & Watson held 25 shares of Global X Genomics & Biotechnology ETF worth $1K as of Q2 2026.
  • Hazlett, Burt & Watson left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #878 holding.
  • Hazlett, Burt & Watson first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and has held it in 18 quarters since.
  • Hazlett, Burt & Watson's Global X Genomics & Biotechnology ETF position peaked at $40K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.